We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
Collection content
305 result(s) found, displaying 201 to 210
-
News articlesThe granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Safety alertsSecond case of thrombosis with thrombocytopenia
-
Media releasesUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
-
News articlesUpdated storage conditions for the Pfizer COVID-19 vaccine
-
Media releasesTGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Media releasesSome rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.
-
Media releasesAustralia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines